L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the effect of oral L-carnitine supplementation during
controlled ovarian stimulation (COS) in patients with polycystic ovary syndrome (PCOS) in a
double-blind randomized clinical trial. The eligible patients with PCOS diagnosis (on the
basis of Rotterdam criteria) who referred to Royan Research Institute for IVF / ICSI
treatment cycles will be evaluated.